Immutep Ltd Adr Stock Revenue
| IMMP Stock | USD 2.12 0.06 2.75% |
Immutep Ltd ADR fundamentals help investors to digest information that contributes to Immutep's financial success or failures. It also enables traders to predict the movement of Immutep Stock. The fundamental analysis module provides a way to measure Immutep's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Immutep stock.
| Last Reported | Projected for Next Year | ||
| Total Revenue | 3.8 M | 2.9 M |
Immutep | Revenue |
Immutep Ltd ADR Company Revenue Analysis
Immutep's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Immutep Revenue | 3.84 M |
Most of Immutep's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Immutep Ltd ADR is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Historical and Projected quarterly revenue of Immutep
Projected quarterly revenue analysis of Immutep Ltd ADR provides investors and stakeholders with an insight into the company's performance and growth prospects. When actual revenues of Immutep match or exceed analyst estimates, it positively influences investor confidence and market perception, often leading to a rise in Immutep's stock price.
Immutep Revenue Driver Correlations
Understanding the fundamental principles of building solid financial models for Immutep is extremely important. It helps to project a fair market value of Immutep Stock properly, considering its historical fundamentals such as Revenue. Since Immutep's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Immutep's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Immutep's interrelated accounts and indicators.
| 0.17 | 0.57 | -0.41 | 0.08 | -0.29 | ||
| 0.17 | 0.26 | -0.61 | 0.93 | 0.62 | ||
| 0.57 | 0.26 | -0.26 | 0.1 | 0.06 | ||
| -0.41 | -0.61 | -0.26 | -0.48 | -0.34 | ||
| 0.08 | 0.93 | 0.1 | -0.48 | 0.53 | ||
| -0.29 | 0.62 | 0.06 | -0.34 | 0.53 |
Click cells to compare fundamentals
Immutep Revenue Historical Pattern
Today, most investors in Immutep Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Immutep's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's revenue growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Immutep revenue as a starting point in their analysis.
Immutep Revenue |
| Timeline |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Immutep Current Deferred Revenue
Current Deferred Revenue |
|
Based on the latest financial disclosure, Immutep Ltd ADR reported 3.84 M of revenue. This is 99.95% lower than that of the Biotechnology sector and 99.48% lower than that of the Health Care industry. The revenue for all United States stocks is 99.96% higher than that of the company.
Immutep Ltd ADR is rated second overall in revenue category among its peers. Market size based on revenue of Health Care industry is currently estimated at about 31.18 Million. Immutep retains roughly 3.84 Million in revenue claiming about 12% of equities under Health Care industry.Immutep Current Valuation Drivers
We derive many important indicators used in calculating different scores of Immutep from analyzing Immutep's financial statements. These drivers represent accounts that assess Immutep's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Immutep's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 61.8M | 310.2M | 229.8M | 257.6M | 296.2M | 294.6M | |
| Enterprise Value | 44.5M | 252.9M | 151.6M | 135.4M | 155.7M | 264.1M |
Immutep ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Immutep's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Immutep's managers, analysts, and investors.Environmental | Governance | Social |
Immutep Institutional Holders
Institutional Holdings refers to the ownership stake in Immutep that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Immutep's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Immutep's value.| Shares | Citadel Advisors Llc | 2024-09-30 | 19.7 K | Geode Capital Management, Llc | 2024-09-30 | 18.7 K | Virtu Financial Llc | 2024-06-30 | 18.6 K | Xtx Topco Ltd | 2024-09-30 | 16.7 K | Morgan Stanley - Brokerage Accounts | 2024-09-30 | 15.1 K | Caption Management, Llc | 2024-09-30 | 12.9 K | Hightower Advisors, Llc | 2024-09-30 | 7.2 K | Wells Fargo & Co | 2024-09-30 | 4.5 K | Bank Of America Corp | 2024-09-30 | 2.5 K | Blackrock Inc | 2024-06-30 | 839.1 K | Meridian Wealth Management, Llc | 2024-09-30 | 398.4 K |
Immutep Fundamentals
| Return On Equity | -0.26 | ||||
| Return On Asset | -0.17 | ||||
| Operating Margin | (13.53) % | ||||
| Current Valuation | 196.45 M | ||||
| Shares Outstanding | 145.46 M | ||||
| Shares Owned By Insiders | 0.01 % | ||||
| Shares Owned By Institutions | 6.26 % | ||||
| Number Of Shares Shorted | 5.13 M | ||||
| Price To Earning | (152.55) X | ||||
| Price To Book | 2.61 X | ||||
| Price To Sales | 81.16 X | ||||
| Revenue | 3.84 M | ||||
| Gross Profit | (32.75 M) | ||||
| EBITDA | (44.54 M) | ||||
| Net Income | (42.72 M) | ||||
| Cash And Equivalents | 80 M | ||||
| Cash Per Share | 0.92 X | ||||
| Total Debt | 1.59 M | ||||
| Debt To Equity | 0.02 % | ||||
| Current Ratio | 14.16 X | ||||
| Book Value Per Share | 0.13 X | ||||
| Cash Flow From Operations | (34.82 M) | ||||
| Short Ratio | 42.18 X | ||||
| Earnings Per Share | (0.25) X | ||||
| Target Price | 9.5 | ||||
| Beta | 1.92 | ||||
| Market Capitalization | 311.82 M | ||||
| Total Asset | 201.58 M | ||||
| Retained Earnings | (382.65 M) | ||||
| Working Capital | 125.19 M | ||||
| Current Asset | 1.89 M | ||||
| Current Liabilities | 1.04 M | ||||
| Net Asset | 201.58 M |
About Immutep Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Immutep Ltd ADR's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Immutep using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Immutep Ltd ADR based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Immutep
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Immutep position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immutep will appreciate offsetting losses from the drop in the long position's value.Moving against Immutep Stock
| 0.71 | GILD | Gilead Sciences | PairCorr |
| 0.65 | BMY | Bristol Myers Squibb | PairCorr |
| 0.5 | FLGC | Flora Growth Corp | PairCorr |
| 0.4 | DNA | Ginkgo Bioworks Holdings | PairCorr |
| 0.39 | GNFT | Genfit | PairCorr |
The ability to find closely correlated positions to Immutep could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Immutep when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Immutep - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Immutep Ltd ADR to buy it.
The correlation of Immutep is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Immutep moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Immutep Ltd ADR moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Immutep can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Immutep Stock Analysis
When running Immutep's price analysis, check to measure Immutep's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immutep is operating at the current time. Most of Immutep's value examination focuses on studying past and present price action to predict the probability of Immutep's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immutep's price. Additionally, you may evaluate how the addition of Immutep to your portfolios can decrease your overall portfolio volatility.